Il costo di una neutropenia febbrile
Febrile neutropenia (FN) is one of the most common and severe complications of chemotherapy, particularly when used for the treatment of hematological malignancies and bone marrow transplantation. Estimating its cost for the National Health service (NHS) is difficult, in that the cost of FN is inclu...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2005-03-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/818 |
| _version_ | 1818249172143308800 |
|---|---|
| author | C. Lucioni L. Crippa O. Leoncini G. Martinelli S. Mazzi A. Santoro |
| author_facet | C. Lucioni L. Crippa O. Leoncini G. Martinelli S. Mazzi A. Santoro |
| author_sort | C. Lucioni |
| collection | DOAJ |
| description | Febrile neutropenia (FN) is one of the most common and severe complications of chemotherapy, particularly when used for the treatment of hematological malignancies and bone marrow transplantation. Estimating its cost for the National Health service (NHS) is difficult, in that the cost of FN is included in the overall reimbursement, which is based on the main DRG declared at discharge. Aim of the present survey, conducted on the patient population treated in two oncology centers in Milan in the years 2001- 2002, was to evaluate the most frequent DRGs associated with neutropenia, with the objective to estimate the mean cost per patient hospitalized with FN. As expected, oncology patients with NF are spread through a wide range of DRGs, but the mean cost per patient resulted comparable in the two considered hospitals ( ~ 9500 euro), as well as the overall distribution among DRGs. The single most frequent DRG was 398 (diseases of reticuloendothelial and immune systems, with complications) which appears to be appropriate, being the closest to the clinical definition of FN available. |
| first_indexed | 2024-12-12T15:32:16Z |
| format | Article |
| id | doaj.art-7b4bd799b57f4b63bcc3a3e3f14d6738 |
| institution | Directory Open Access Journal |
| issn | 2240-256X |
| language | English |
| last_indexed | 2024-12-12T15:32:16Z |
| publishDate | 2005-03-01 |
| publisher | SEEd Medical Publishers |
| record_format | Article |
| series | Farmeconomia: Health Economics and Therapeutic Pathways |
| spelling | doaj.art-7b4bd799b57f4b63bcc3a3e3f14d67382022-12-22T00:20:06ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2005-03-0161212410.7175/fe.v6i1.818763Il costo di una neutropenia febbrileC. Lucioni0L. Crippa1O. Leoncini2G. Martinelli3S. Mazzi4A. Santoro5Wolters Kluwer Health, ADIS International, Milano
Amgen Italia
Istituto Clinico Humanitas, Dipartimento di Scienze Onco-ematologiche
Istituto Europeo di Oncologia, Divisione Onco-ematologica
Wolters Kluwer Health, ADIS International, Milano
Istituto Clinico Humanitas, Dipartimento di Scienze Onco-ematologiche
Febrile neutropenia (FN) is one of the most common and severe complications of chemotherapy, particularly when used for the treatment of hematological malignancies and bone marrow transplantation. Estimating its cost for the National Health service (NHS) is difficult, in that the cost of FN is included in the overall reimbursement, which is based on the main DRG declared at discharge. Aim of the present survey, conducted on the patient population treated in two oncology centers in Milan in the years 2001- 2002, was to evaluate the most frequent DRGs associated with neutropenia, with the objective to estimate the mean cost per patient hospitalized with FN. As expected, oncology patients with NF are spread through a wide range of DRGs, but the mean cost per patient resulted comparable in the two considered hospitals ( ~ 9500 euro), as well as the overall distribution among DRGs. The single most frequent DRG was 398 (diseases of reticuloendothelial and immune systems, with complications) which appears to be appropriate, being the closest to the clinical definition of FN available.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/818febrile neutropeniachemotherapydrg |
| spellingShingle | C. Lucioni L. Crippa O. Leoncini G. Martinelli S. Mazzi A. Santoro Il costo di una neutropenia febbrile Farmeconomia: Health Economics and Therapeutic Pathways febrile neutropenia chemotherapy drg |
| title | Il costo di una neutropenia febbrile |
| title_full | Il costo di una neutropenia febbrile |
| title_fullStr | Il costo di una neutropenia febbrile |
| title_full_unstemmed | Il costo di una neutropenia febbrile |
| title_short | Il costo di una neutropenia febbrile |
| title_sort | il costo di una neutropenia febbrile |
| topic | febrile neutropenia chemotherapy drg |
| url | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/818 |
| work_keys_str_mv | AT clucioni ilcostodiunaneutropeniafebbrile AT lcrippa ilcostodiunaneutropeniafebbrile AT oleoncini ilcostodiunaneutropeniafebbrile AT gmartinelli ilcostodiunaneutropeniafebbrile AT smazzi ilcostodiunaneutropeniafebbrile AT asantoro ilcostodiunaneutropeniafebbrile |